ConductScience.org, home

Paper34278671

Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.

Su X and 7 others. Angew Chem Int Ed Engl, 2021. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*. Papers, record 34278671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34278671

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.
PubMed
Journal
Angew Chem Int Ed Engl
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2022-07-16
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Su XXiaoxuan
2Ma WWenxiao
3Feng DDi
4Cheng BBoyang
5Wang QQian
6Guo ZZefeng
7Zhou DDemin
8Tang XXinjinghttps://orcid.org/0000-0002-9959-1167

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
EndoribonucleasesMajor topic
Enzyme ActivationMajor topic
Oligonucleotides, AntisenseMajor topic
SARS-CoV-2Major topic
Animals
Chlorocebus aethiops
Coronavirus Envelope Proteins
Drug Design
HEK293 Cells
Humans
Hydrolysis
Microbial Sensitivity Tests
Mutation
RNA, Viral
Spike Glycoprotein, Coronavirus
Vero Cells

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
21877001National Natural Science Foundation of ChinaPubMed
22077005National Natural Science Foundation of ChinaPubMed
81821004National Natural Science Foundation of ChinaPubMed
2017ZX09303013Ministry of Science and Technology of the People's Republic of ChinaPubMed

Source PubMed

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131494033Concerted 2-5A-Mediated mRNA Decay and Transcription Reprogram Protein Synthesis in the dsRNA Response.Mol Cell2019https://conductscience.org/library/papers/31494033PubMed
231964809Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/31964809PubMed
327097021Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs.ACS Chem Biol2016https://conductscience.org/library/papers/27097021PubMed
428484023Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28484023PubMed
522704621Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology.Cell Host Microbe2012https://conductscience.org/library/papers/22704621PubMed
633762737Antisense technology: an overview and prospectus.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33762737PubMed
734278671Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.Angew Chem Int Ed Engl2021https://conductscience.org/library/papers/34278671PubMed
828808124Rapid RNase L-driven arrest of protein synthesis in the dsRNA response without degradation of translation machinery.RNA2017https://conductscience.org/library/papers/28808124PubMed
99050883Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9050883PubMed
1031130520Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.Cell Chem Biol2019https://conductscience.org/library/papers/31130520PubMed
117679499Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7679499PubMed
1232295917RNase L Amplifies Interferon Signaling by Inducing Protein Kinase R-Mediated Antiviral Stress Granules.J Virol2020https://conductscience.org/library/papers/32295917PubMed
1323084743Innate immune messenger 2-5A tethers human RNase L into active high-order complexes.Cell Rep2012https://conductscience.org/library/papers/23084743PubMed
1432782413Advances in oligonucleotide drug delivery.Nat Rev Drug Discov2020https://conductscience.org/library/papers/32782413PubMed
1530004000PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy.J Control Release2018https://conductscience.org/library/papers/30004000PubMed
1630467074Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis.J Cyst Fibros2019https://conductscience.org/library/papers/30467074PubMed
1732648313Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.Rev Med Virol2020https://conductscience.org/library/papers/32648313PubMed
1831494035RNase L Reprograms Translation by Widespread mRNA Turnover Escaped by Antiviral mRNAs.Mol Cell2019https://conductscience.org/library/papers/31494035PubMed
1932104389Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery.Asian J Pharm Sci2018https://conductscience.org/library/papers/32104389PubMed
2033140033Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders.ACS Cent Sci2020https://conductscience.org/library/papers/33140033PubMed

See all 26 referencesDownload CSV of references

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42239496Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42239496PubMed
42171504Extending the Targets for Coronavirus Antivirals Beyond That of Approved Drugs: Insights From Preclinical Research.Microb Biotechnol2026https://conductscience.org/library/papers/42171504PubMed
41596370Application of Orthoflavivirus Pseudovirus Technology in Antiviral Research.Int J Mol Sci2026https://conductscience.org/library/papers/41596370PubMed
41130951DNA computing function switching by programming base stacking interactions with minimal molecular architecture changes.Nat Commun2025https://conductscience.org/library/papers/41130951PubMed
41042259PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens.FEMS Microbiol Rev2025https://conductscience.org/library/papers/41042259PubMed
40686860Antisense oligonucleotides targeting the SARS-CoV-2 nucleocapsid gene decrease viral titers in hamsters.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40686860PubMed
40427100Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression.Cancers (Basel)2025https://conductscience.org/library/papers/40427100PubMed
39990950Nucleic Acid Conjugates: Unlocking Therapeutic Potential.ACS Bio Med Chem Au2025https://conductscience.org/library/papers/39990950PubMed
39779694Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region.Nat Commun2025https://conductscience.org/library/papers/39779694PubMed
39727035The Unusual Role of Ribonuclease L in Innate Immunity.Wiley Interdiscip Rev RNA2024https://conductscience.org/library/papers/39727035PubMed
39630134Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition.RNA Biol2024https://conductscience.org/library/papers/39630134PubMed
38641489Heterobifunctional small molecules to modulate RNA function.Trends Pharmacol Sci2024https://conductscience.org/library/papers/38641489PubMed
38598625Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera.Sci Adv2024https://conductscience.org/library/papers/38598625PubMed
37066172Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region.bioRxiv2023https://conductscience.org/library/papers/37066172PubMed
36735698Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.PLoS One2023https://conductscience.org/library/papers/36735698PubMed
36714073Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection.Cell Rep Phys Sci2023https://conductscience.org/library/papers/36714073PubMed
36675069DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning.Int J Mol Sci2023https://conductscience.org/library/papers/36675069PubMed
36674746Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors.Int J Mol Sci2023https://conductscience.org/library/papers/36674746PubMed
36551374A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery.Antibiotics (Basel)2022https://conductscience.org/library/papers/36551374PubMed
36139095Recent Advances of Degradation Technologies Based on PROTAC Mechanism.Biomolecules2022https://conductscience.org/library/papers/36139095PubMed

See all 26 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RNASEL6041PubTator's text mininghttps://conductscience.org/library/genes/6041

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34278671

GET https://conductscience.org/api/papers/v1/34278671/references?page=2